|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.33/-0.25
|
企業價值
1.31B
|
資產負債 |
每股賬面淨值
2.02
|
現金流量 |
現金流量率
--
|
損益表 |
收益
863.50M
|
每股收益
1.25
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/09/27 20:09 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals. |